Login
value-dx
  • About us
    • What is VALUE-Dx?
    • Governance
    • The Consortium
  • Work Packages
    • Work Package 1
    • Work Package 2
    • Work Package 3
    • Work Package 4
    • Work Package 5
    • Work Package 6
    • Work package 7
  • WAAW Campaign
    • WAAW Campaign 2020
    • WAAW Campaign 2019
  • News & Events
    • News
    • Press
    • Events
  • Publications
    • Communication Resources
    • Scientific Publications
  • Contact
  • VALUE-Dx E-learning Platform
  • Search
  • Menu
  • About us
    • What is VALUE-Dx?
    • Governance
    • The Consortium
  • Work Packages
    • Work Package 1
    • Work Package 2
    • Work Package 3
    • Work Package 4
    • Work Package 5
    • Work Package 6
    • Work package 7
  • WAAW Campaign
    • WAAW Campaign 2020
    • WAAW Campaign 2019
  • News & Events
    • News
    • Press
    • Events
  • Publications
    • Communication Resources
    • Scientific Publications
  • Contact
  • VALUE-Dx E-learning Platform

Archive for month: June, 2020

You are here: Home / 2020 / June
News

Evaluating the clinical and cost-effectiveness of CA-ARTI diagnostics through PRUDENCE trial

June 26, 2020
https://value-dx.eu/wp-content/uploads/2019/09/VALUE-Dx_logo_white4.png 428 1226 Tina Hofland https://value-dx.eu/wp-content/uploads/2019/07/Logo-300x124.png Tina Hofland2020-06-26 11:31:312020-09-21 13:30:39Evaluating the clinical and cost-effectiveness of CA-ARTI diagnostics through PRUDENCE trial
News

RECOVER builds on the work of VALUE-Dx to combat COVID-19 pandemic

June 26, 2020
https://value-dx.eu/wp-content/uploads/2019/09/VALUE-Dx_logo_white4.png 428 1226 Tina Hofland https://value-dx.eu/wp-content/uploads/2019/07/Logo-300x124.png Tina Hofland2020-06-26 09:42:352020-09-21 13:30:56RECOVER builds on the work of VALUE-Dx to combat COVID-19 pandemic
News

Review and analysis of diagnostic test accuracy for CA-ARTI

June 18, 2020
https://value-dx.eu/wp-content/uploads/2019/09/VALUE-Dx_logo_white4.png 428 1226 Daniele Pazzola https://value-dx.eu/wp-content/uploads/2019/07/Logo-300x124.png Daniele Pazzola2020-06-18 13:37:112020-09-21 13:31:14Review and analysis of diagnostic test accuracy for CA-ARTI
News

Enhancing the quality of antibiotic prescribing for CA-ARTI in Emergency Rooms through ADEQUATE trial

June 17, 2020
https://value-dx.eu/wp-content/uploads/2019/09/VALUE-Dx_logo_white4.png 428 1226 Daniele Pazzola https://value-dx.eu/wp-content/uploads/2019/07/Logo-300x124.png Daniele Pazzola2020-06-17 13:35:562020-09-21 13:31:30Enhancing the quality of antibiotic prescribing for CA-ARTI in Emergency Rooms through ADEQUATE trial
News

VALUE-Dx work on investigating value of diagnostics

June 9, 2020
https://value-dx.eu/wp-content/uploads/2019/09/VALUE-Dx_logo_white4.png 428 1226 Daniele Pazzola https://value-dx.eu/wp-content/uploads/2019/07/Logo-300x124.png Daniele Pazzola2020-06-09 11:56:482020-09-21 13:31:48VALUE-Dx work on investigating value of diagnostics
News

VALUE-Dx gets ready for clinical trials

June 8, 2020
https://value-dx.eu/wp-content/uploads/2019/09/VALUE-Dx_logo_white4.png 428 1226 Daniele Pazzola https://value-dx.eu/wp-content/uploads/2019/07/Logo-300x124.png Daniele Pazzola2020-06-08 13:51:142020-09-21 13:32:21VALUE-Dx gets ready for clinical trials

Social Media

Twitter
LinkedIn

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 820755. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and bioMérieux SA, Janssen Pharmaceutica NV, Accelerate Diagnostics S.L., Abbott, Bio-Rad Laboratories, BD Switzerland Sàrl, and The Wellcome Trust Limited.

Copyright - Value-Dx - The communication reflects the author's view and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained therein.
Scroll to top
We use cookies to ensure that we can give you the best experience on our website. AcceptRefuseRead More